Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
33.50
+1.00 (3.08%)
Apr 29, 2026, 1:16 PM IDT

TLV:CBI Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
50.98M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023104.00K-266.00K-71.89%
Dec 31, 2022370.00K146.00K65.18%
Dec 31, 2021224.00K18.00K8.74%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
BioLineRx 3.76M
Evogene 12.28M
BioLight Life Sciences 21.00K
Can-Fite BioPharma 1.29M
XTL Biopharmaceuticals 3.26M
Geffen Residence & Renewal 78.00K
Revenue Rankings